In addition to reviewing clinical plans and study designs for Jerini's development projects, the company's Clinical Advisory Board also provides strategic advice supporting the advancement of its drug candidates through the regulatory process.

Prof. Dr. Konrad Bork
Department of Dermatology, Johannes Gutenberg University, Mainz, Germany
 

Prof. Dr. Bertram Wiedenmann
Medical Faculty Charité, Humboldt University, Berlin, Germany